157 related articles for article (PubMed ID: 35714735)
1. Adeno-Associated Virus Serotype 2-hCHM Subretinal Delivery to the Macula in Choroideremia: Two-Year Interim Results of an Ongoing Phase I/II Gene Therapy Trial.
Aleman TS; Huckfeldt RM; Serrano LW; Pearson DJ; Vergilio GK; McCague S; Marshall KA; Ashtari M; Doan TM; Weigel-DiFranco CA; Biron BS; Wen XH; Chung DC; Liu E; Ferenchak K; Morgan JIW; Pierce EA; Eliott D; Bennett J; Comander J; Maguire AM
Ophthalmology; 2022 Oct; 129(10):1177-1191. PubMed ID: 35714735
[TBL] [Abstract][Full Text] [Related]
2. Short-term Assessment of Subfoveal Injection of Adeno-Associated Virus-Mediated hCHM Gene Augmentation in Choroideremia Using Adaptive Optics Ophthalmoscopy.
Morgan JIW; Jiang YY; Vergilio GK; Serrano LW; Pearson DJ; Bennett J; Maguire AM; Aleman TS
JAMA Ophthalmol; 2022 Apr; 140(4):411-420. PubMed ID: 35266957
[TBL] [Abstract][Full Text] [Related]
3. Two-Year Results After AAV2-Mediated Gene Therapy for Choroideremia: The Alberta Experience.
Dimopoulos IS; Hoang SC; Radziwon A; Binczyk NM; Seabra MC; MacLaren RE; Somani R; Tennant MTS; MacDonald IM
Am J Ophthalmol; 2018 Sep; 193():130-142. PubMed ID: 29940166
[TBL] [Abstract][Full Text] [Related]
4. Choroideremia Gene Therapy Phase 2 Clinical Trial: 24-Month Results.
Lam BL; Davis JL; Gregori NZ; MacLaren RE; Girach A; Verriotto JD; Rodriguez B; Rosa PR; Zhang X; Feuer WJ
Am J Ophthalmol; 2019 Jan; 197():65-73. PubMed ID: 30240725
[TBL] [Abstract][Full Text] [Related]
5. Technique of retinal gene therapy: delivery of viral vector into the subretinal space.
Xue K; Groppe M; Salvetti AP; MacLaren RE
Eye (Lond); 2017 Sep; 31(9):1308-1316. PubMed ID: 28820183
[TBL] [Abstract][Full Text] [Related]
6. AAV2-Mediated Gene Therapy for Choroideremia: 5-Year Results and Alternate Anti-sense Oligonucleotide Therapy.
Zhai Y; Xu M; Radziwon A; Dimopoulos IS; Crichton P; Mah R; MacLaren RE; Somani R; Tennant MT; MacDonald IM
Am J Ophthalmol; 2023 Apr; 248():145-156. PubMed ID: 36581191
[TBL] [Abstract][Full Text] [Related]
7. Multimodal assessment of choroideremia patients defines pre-treatment characteristics.
Seitz IP; Zhour A; Kohl S; Llavona P; Peter T; Wilhelm B; Zrenner E; Ueffing M; Bartz-Schmidt KU; Fischer MD
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2143-50. PubMed ID: 25744334
[TBL] [Abstract][Full Text] [Related]
8. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial.
MacLaren RE; Groppe M; Barnard AR; Cottriall CL; Tolmachova T; Seymour L; Clark KR; During MJ; Cremers FP; Black GC; Lotery AJ; Downes SM; Webster AR; Seabra MC
Lancet; 2014 Mar; 383(9923):1129-37. PubMed ID: 24439297
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Retinal Gene Therapy Using Adeno-Associated Virus Vector for Patients With Choroideremia: A Randomized Clinical Trial.
Fischer MD; Ochakovski GA; Beier B; Seitz IP; Vaheb Y; Kortuem C; Reichel FFL; Kuehlewein L; Kahle NA; Peters T; Girach A; Zrenner E; Ueffing M; MacLaren RE; Bartz-Schmidt KU; Wilhelm B
JAMA Ophthalmol; 2019 Nov; 137(11):1247-1254. PubMed ID: 31465092
[TBL] [Abstract][Full Text] [Related]
10. Structural and Functional Recovery Following Limited Iatrogenic Macular Detachment for Retinal Gene Therapy.
Simunovic MP; Xue K; Jolly JK; MacLaren RE
JAMA Ophthalmol; 2017 Mar; 135(3):234-241. PubMed ID: 28152124
[TBL] [Abstract][Full Text] [Related]
11. Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial.
Ghazi NG; Abboud EB; Nowilaty SR; Alkuraya H; Alhommadi A; Cai H; Hou R; Deng WT; Boye SL; Almaghamsi A; Al Saikhan F; Al-Dhibi H; Birch D; Chung C; Colak D; LaVail MM; Vollrath D; Erger K; Wang W; Conlon T; Zhang K; Hauswirth W; Alkuraya FS
Hum Genet; 2016 Mar; 135(3):327-43. PubMed ID: 26825853
[TBL] [Abstract][Full Text] [Related]
12. Characterizing the Natural History of Visual Function in Choroideremia Using Microperimetry and Multimodal Retinal Imaging.
Jolly JK; Xue K; Edwards TL; Groppe M; MacLaren RE
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5575-5583. PubMed ID: 29084330
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Genetic Features of Choroideremia in Childhood.
Khan KN; Islam F; Moore AT; Michaelides M
Ophthalmology; 2016 Oct; 123(10):2158-65. PubMed ID: 27506488
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of Disease Severity and Phenotype in Choroideremia Carriers.
Jauregui R; Park KS; Tanaka AJ; Cho A; Paavo M; Zernant J; Francis JH; Allikmets R; Sparrow JR; Tsang SH
Am J Ophthalmol; 2019 Nov; 207():77-86. PubMed ID: 31181178
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of Rab escort protein 1 following AAV2-mediated gene delivery in the retina of choroideremia mice and human cells ex vivo.
Tolmachova T; Tolmachov OE; Barnard AR; de Silva SR; Lipinski DM; Walker NJ; Maclaren RE; Seabra MC
J Mol Med (Berl); 2013 Jul; 91(7):825-37. PubMed ID: 23756766
[TBL] [Abstract][Full Text] [Related]
16. Peculiar Clinical Findings in Young Choroideremia Patients: A Retrospective Case Review.
Mucciolo DP; Murro V; Sodi A; Passerini I; Giorgio D; Virgili G; Rizzo S
Ophthalmologica; 2019; 242(4):195-207. PubMed ID: 31416074
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated virus 8-mediated gene therapy for choroideremia: preclinical studies in in vitro and in vivo models.
Black A; Vasireddy V; Chung DC; Maguire AM; Gaddameedi R; Tolmachova T; Seabra M; Bennett J
J Gene Med; 2014; 16(5-6):122-30. PubMed ID: 24962736
[TBL] [Abstract][Full Text] [Related]
18. Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study.
Aleman TS; Han G; Serrano LW; Fuerst NM; Charlson ES; Pearson DJ; Chung DC; Traband A; Pan W; Ying GS; Bennett J; Maguire AM; Morgan JI
Ophthalmology; 2017 Mar; 124(3):359-373. PubMed ID: 27986385
[TBL] [Abstract][Full Text] [Related]
19. Choroideremia: molecular mechanisms and development of AAV gene therapy.
Patrício MI; Barnard AR; Xue K; MacLaren RE
Expert Opin Biol Ther; 2018 Jul; 18(7):807-820. PubMed ID: 29932012
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
